Home LiteratureArticle Details
PMID: 17065207 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution.

Journal of virology ·Vol. 81 ·No. 1 ·2007-01-00 ·Pages 193-201

Li B, Gladden AD, Altfeld M, Kaldor JM, Cooper DA, Kelleher AD, Allen TM

Abstract

The error-prone replication of human immunodeficiency virus type 1 (HIV-1) enables it to continuously evade host CD8+ T-cell responses. The observed transmission, and potential accumulation, of CD8+ T-cell escape mutations in the population may suggest a gradual adaptation of HIV-1 to immune pressures. Recent reports, however, have highlighted the propensity of some escape mutations to revert upon transmission to a new host in order to restore efficient replication capacity. To more specifically address the role of reversions in early HIV-1 evolution, we examined sequence polymorphisms arising across the HIV-1 genome in seven subjects followed longitudinally 1 year from primary infection. As expected, numerous nonsynonymous mutations were associated with described CD8+ T-cell epitopes, supporting a prominent role for cellular immune responses in driving early HIV-1 evolution. Strikingly, however, a substantial proportion of substitutions (42%) reverted toward the clade B consensus sequence, with nearly one-quarter of them located within defined CD8 epitopes not restricted by the contemporary host's HLA. More importantly, these reversions arose significantly faster than forward mutations, with the most rapidly reverting mutations preferentially arising within structurally conserved residues. These data suggest that many transmitted mutations likely incur a fitness cost that is recovered through retrieval of an optimal, or ancestral, form of the virus. The propensity of mutations to revert may limit the accumulation of immune pressure-driven mutations in the population, thus preserving critical CD8+ T-cell epitopes as vaccine targets, and argue against an unremitting adaptation of HIV-1 to host immune pressures.

MeSH Terms
CD8-Positive T-Lymphocytes/immunology Evolution, Molecular Genome, Viral HIV Infections/immunology,transmission,virology HIV-1/genetics,physiology Humans Polymorphism, Genetic Virus Replication
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Li Bin
Partners AIDS Research Center, MGH-East, CNY 6616, 149 13th Street, Charlestown, MA 02129, USA.
Gladden Adrianne D
Altfeld Marcus
Kaldor John M
Cooper David A
Kelleher Anthony D
Allen Todd M
References (68)
68 references, click to expand
  1. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control.
    J Virol. 2006 Mar;80(6):3122-5 PMID: 16501126
  2. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.
    J Virol. 2006 Apr;80(7):3617-23 PMID: 16537629
  3. Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus.
    J Exp Med. 2006 Mar 20;203(3):529-39 PMID: 16533886
  4. Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes.
    J Virol Methods. 2006 Sep;136(1-2):118-25 PMID: 16701907
  5. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS.
    Nat Med. 1997 Feb;3(2):212-7 PMID: 9018241
  6. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection.
    Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1890-5 PMID: 9050875
  7. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.
    Science. 1997 Nov 21;278(5342):1447-50 PMID: 9367954
  8. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.
    Science. 1999 Feb 5;283(5403):857-60 PMID: 9933172
  9. Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection.
    J Clin Invest. 1999 Nov;104(10):1431-9 PMID: 10562305
  10. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.
    Nature. 2000 Sep 21;407(6802):386-90 PMID: 11014195
  11. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.
    J Exp Med. 2001 Jan 15;193(2):169-80 PMID: 11148221
  12. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.
    J Exp Med. 2001 Feb 5;193(3):375-86 PMID: 11157057
  13. Evolution and transmission of stable CTL escape mutations in HIV infection.
    Nature. 2001 Jul 19;412(6844):334-8 PMID: 11460164
  14. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.
    Nat Med. 2002 May;8(5):493-9 PMID: 11984594
  15. T cell dynamics in HIV-1 infection.
    Annu Rev Immunol. 2003;21:265-304 PMID: 12524385
  16. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.
    J Immunol Methods. 2003 Apr 1;275(1-2):19-29 PMID: 12667667
  17. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection.
    J Virol. 2003 Jun;77(12):6867-78 PMID: 12768006
  18. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences.
    J Virol. 2003 Jul;77(13):7330-40 PMID: 12805431
  19. Advantage of rare HLA supertype in HIV disease progression.
    Nat Med. 2003 Jul;9(7):928-35 PMID: 12819779
  20. Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection.
    J Immunol. 2003 Oct 1;171(7):3837-46 PMID: 14500685
  21. Gradual adaptation of HIV to human host populations: good or bad news?
    Nat Med. 2003 Nov;9(11):1359-62 PMID: 14595431
  22. Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual.
    J Virol. 2003 Dec;77(23):12430-40 PMID: 14610167
  23. Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus.
    Clin Infect Dis. 2003 Dec 15;37(12):1693-8 PMID: 14689353
  24. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    J Virol. 2004 Feb;78(3):1324-32 PMID: 14722287
  25. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities.
    J Virol. 2004 Mar;78(5):2187-200 PMID: 14963115
  26. HIV evolution: CTL escape mutation and reversion after transmission.
    Nat Med. 2004 Mar;10(3):282-9 PMID: 14770175
  27. Reversion of CTL escape-variant immunodeficiency viruses in vivo.
    Nat Med. 2004 Mar;10(3):275-81 PMID: 14966520
  28. HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load.
    J Infect Dis. 2004 Apr 1;189(7):1199-208 PMID: 15031788
  29. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection.
    J Exp Med. 2004 Apr 5;199(7):905-15 PMID: 15067030
  30. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
    J Virol. 2004 Jul;78(13):7069-78 PMID: 15194783
  31. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.
    J Exp Med. 2004 Jun 21;199(12):1709-18 PMID: 15210746
  32. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    J Virol. 2004 Jul;78(14):7545-52 PMID: 15220429
  33. Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes.
    AIDS. 2004 Jul 23;18(11):1595-8 PMID: 15238779
  34. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
    J Infect Dis. 2004 Aug 15;190(4):713-21 PMID: 15272399
  35. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.
    J Exp Med. 2004 Sep 20;200(6):749-59 PMID: 15365096
  36. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells.
    J Exp Med. 2004 Sep 20;200(6):701-12 PMID: 15381726
  37. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa.
    J Immunol. 2004 Oct 1;173(7):4607-17 PMID: 15383595
  38. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    J Virol. 1994 Jul;68(7):4650-5 PMID: 8207839
  39. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
    J Virol. 1994 Sep;68(9):6103-10 PMID: 8057491
  40. Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction.
    Virology. 1995 Oct 20;213(1):80-6 PMID: 7483282
  41. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection.
    Nat Med. 1996 Apr;2(4):405-11 PMID: 8597949
  42. Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C.
    AIDS Res Hum Retroviruses. 1996 Sep 20;12(14):1329-39 PMID: 8891112
  43. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.
    Nat Med. 1997 Feb;3(2):205-11 PMID: 9018240
  44. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    Science. 2002 May 24;296(5572):1439-43 PMID: 12029127
  45. Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection.
    J Virol. 2002 Sep;76(17):8690-701 PMID: 12163589
  46. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.
    J Virol. 2002 Sep;76(17):8757-68 PMID: 12163596
  47. Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children.
    J Infect Dis. 2002 Dec 1;186(11):1589-96 PMID: 12447734
  48. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.
    Nature. 2002 Nov 28;420(6914):434-9 PMID: 12459786
  49. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection.
    J Virol. 2003 Jan;77(2):882-90 PMID: 12502804
  50. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.
    J Virol. 2003 Feb;77(3):2081-92 PMID: 12525643
  51. Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity.
    J Infect Dis. 2003 Jan 15;187(2):226-42 PMID: 12552447
  52. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.
    Science. 1999 Mar 12;283(5408):1748-52 PMID: 10073943
  53. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.
    J Exp Med. 1999 Mar 15;189(6):991-8 PMID: 10075982
  54. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response.
    J Exp Med. 2004 Nov 15;200(10):1243-56 PMID: 15545352
  55. Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope.
    J Virol. 2004 Dec;78(24):13901-10 PMID: 15564498
  56. A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation.
    J Virol. 2004 Dec;78(24):14012-22 PMID: 15564508
  57. CD8 epitope escape and reversion in acute HCV infection.
    J Exp Med. 2004 Dec 20;200(12):1593-604 PMID: 15611288
  58. Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains.
    J Virol. 2005 Jan;79(2):860-8 PMID: 15613314
  59. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA.
    J Exp Med. 2005 Mar 21;201(6):891-902 PMID: 15781581
  60. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
    J Virol. 2005 Apr;79(8):5000-5 PMID: 15795285
  61. Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost.
    J Virol. 2005 May;79(9):5721-31 PMID: 15827187
  62. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus.
    J Exp Med. 2005 Jun 6;201(11):1753-9 PMID: 15939791
  63. Limited sequence evolution within persistently targeted CD8 epitopes in chronic human immunodeficiency virus type 1 infection.
    J Virol. 2005 Jul;79(13):8171-81 PMID: 15956562
  64. Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes.
    J Virol. 2005 Sep;79(17):11523-8 PMID: 16103205
  65. CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef.
    J Immunol. 2005 Oct 1;175(7):4618-26 PMID: 16177107
  66. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.
    J Virol. 2005 Nov;79(21):13239-49 PMID: 16227247
  67. CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals.
    Virology. 2006 Feb 5;345(1):209-19 PMID: 16246391
  68. Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host.
    J Virol. 2006 Feb;80(4):1637-44 PMID: 16439520
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2007-01-00
Epub
2006-00-25
Pages
193-201
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC1797245
Subset
IM
Grants
NIAID NIH HHS · R01 AI054178 · United States
NIAID NIH HHS · R21 AI067078 · United States
NIAID NIH HHS · R01-AI054178 · United States
NIAID NIH HHS · R21-AI067078 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]